GPT and liver disorder: In the WD-based mouse model, on the other hand, we did not observe notable differences in liver disease markers, including liver–body weight ratio (p = 0.779), hepatic triglycerides (p = 0.492), and ALT levels (p = 0.613), or in the histological analysis between the Na-butyrate group and the control group (Figure S2a–h).